HYFT (MindWalk Holdings) Short-Term Debt to Capital

Corporate company logo of MindWalk Holdings (HYFT)

MindWalk Holdings (HYFT) develops SaaS tools for high-precision biodata analysis, ensuring high profitability and a steady cash flow. The company is currently focusing on integrating AI into the green energy sector through partnerships with EV charging station operators while avoiding mergers. This price chart reflects the 0.10 metric, yet the business remains dependent on the success of external biotech partners due to a lack of its own proprietary drugs.

Ratio of Short-Term Indebtedness to Capital: MindWalk (HYFT) for 09/05/2025 - 11/01/2026

Analytical breakdowns for MindWalk Holdings

- stock quotes and analyst forecast:
Stock Price MindWalk|HYFT - Fair Value Consensus
- business market valuation indicators:
Market Capitalization MindWalk Holdings, Inc.|HYFT - Enterprise Value
- book capitalization information:
Net Assets per Single Share MindWalk Holdings|HYFT - Accounting Value of Company|Market Value to Book Value Ratio ipatherapeutics.com|HYFT - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital MindWalk Holdings|HYFT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio MindWalk Holdings Inc.|HYFT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio MindWalk Holdings, Inc.|HYFT - Long-Term Debt|Company Current Liabilities MindWalk Holdings|Quick Ratio ipatherapeutics.com
- company profitability and valuation multiples indicators:
HYFT - Final Profit
Fundamental valuation:HYFT MindWalk
Brand item of MindWalk Holdings, Inc.

This ratio correlates liabilities with a maturity of up to one year with equity, measuring liquidity dependence on short-term borrowing and the risk of cash flow gaps. By analyzing the dynamics of the short-term debt load, an investor assesses the financial stability of MindWalk Holdings (HYFT), whose AI-development digital logistics model minimizes physical R&D expenditures, optimizing the capital structure by reducing operating costs.

Competitors of MindWalk Holdings (HYFT)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|EXOZ - Short-Term Debt to Equity Ratio|Oramed Pharma - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Entera Bio Ltd. ENTX|ABVC BioPharma (ABVC) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio CPIX|QNTM (Quantum BioPharma) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio FGEN (FibroGen Inc)|Short-Term Debt to Equity Ratio TELO (Telomir Pharma)|Short-Term Debt to Equity Ratio ranitherapeutics.com RANI|Short-Term Debt to Capital SNYR (Synergy CHC)|Short-Term Debt to Capital Rallybio Corp RLYB|LEXX - Short-Term Debt to Equity|PULM: Short-Term Debt to Equity|ftzy.com.cn (PTHL) - Short-Term Debt to Equity|Aptorum Group (APM) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio LYRA|IBO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TNFA|YCBD (cbdmd.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity PainReform Limited PRFX|Altamira Therapeutics Ltd (CYTO) - Current Liabilities to Capital|LIPO - Short-Term Debt to Equity|OPTN: Short-Term Debt to Equity|PIRS: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio PROC|PTPI (Petros) - Short-Term Debt to Capital|Qilian International Corp (QLI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|tffpharma.com - Short-Term Debt to Capital Ratio